| pubmed-article:19958893 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19958893 | lifeskim:mentions | umls-concept:C0013227 | lld:lifeskim |
| pubmed-article:19958893 | lifeskim:mentions | umls-concept:C0205245 | lld:lifeskim |
| pubmed-article:19958893 | lifeskim:mentions | umls-concept:C0449820 | lld:lifeskim |
| pubmed-article:19958893 | lifeskim:mentions | umls-concept:C0918012 | lld:lifeskim |
| pubmed-article:19958893 | lifeskim:mentions | umls-concept:C2828008 | lld:lifeskim |
| pubmed-article:19958893 | pubmed:issue | 12 | lld:pubmed |
| pubmed-article:19958893 | pubmed:dateCreated | 2009-12-4 | lld:pubmed |
| pubmed-article:19958893 | pubmed:abstractText | The Drug Burden Index (DBI), a measure of exposure to anticholinergic and sedative medications, has been independently associated with physical and cognitive function in a cross-sectional analysis of community-dwelling older persons participating in the Health, Aging and Body Composition study. Here we evaluate the association between DBI and functional outcomes in Health, Aging and Body Composition study participants over 5 years. | lld:pubmed |
| pubmed-article:19958893 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19958893 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19958893 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19958893 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19958893 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19958893 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:19958893 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19958893 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19958893 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19958893 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:19958893 | pubmed:issn | 1555-7162 | lld:pubmed |
| pubmed-article:19958893 | pubmed:author | pubmed-author:Health ABC... | lld:pubmed |
| pubmed-article:19958893 | pubmed:author | pubmed-author:HarrisTamara... | lld:pubmed |
| pubmed-article:19958893 | pubmed:author | pubmed-author:AbernethyDarr... | lld:pubmed |
| pubmed-article:19958893 | pubmed:author | pubmed-author:ShorrRonald... | lld:pubmed |
| pubmed-article:19958893 | pubmed:author | pubmed-author:BauerDouglas... | lld:pubmed |
| pubmed-article:19958893 | pubmed:author | pubmed-author:SimonsickElea... | lld:pubmed |
| pubmed-article:19958893 | pubmed:author | pubmed-author:MagerDonald... | lld:pubmed |
| pubmed-article:19958893 | pubmed:author | pubmed-author:LingShari MSM | lld:pubmed |
| pubmed-article:19958893 | pubmed:author | pubmed-author:WindhamB... | lld:pubmed |
| pubmed-article:19958893 | pubmed:author | pubmed-author:HilmerSarah... | lld:pubmed |
| pubmed-article:19958893 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19958893 | pubmed:volume | 122 | lld:pubmed |
| pubmed-article:19958893 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19958893 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19958893 | pubmed:pagination | 1142-1149.e1-2 | lld:pubmed |
| pubmed-article:19958893 | pubmed:meshHeading | pubmed-meshheading:19958893... | lld:pubmed |
| pubmed-article:19958893 | pubmed:meshHeading | pubmed-meshheading:19958893... | lld:pubmed |
| pubmed-article:19958893 | pubmed:meshHeading | pubmed-meshheading:19958893... | lld:pubmed |
| pubmed-article:19958893 | pubmed:meshHeading | pubmed-meshheading:19958893... | lld:pubmed |
| pubmed-article:19958893 | pubmed:meshHeading | pubmed-meshheading:19958893... | lld:pubmed |
| pubmed-article:19958893 | pubmed:meshHeading | pubmed-meshheading:19958893... | lld:pubmed |
| pubmed-article:19958893 | pubmed:meshHeading | pubmed-meshheading:19958893... | lld:pubmed |
| pubmed-article:19958893 | pubmed:meshHeading | pubmed-meshheading:19958893... | lld:pubmed |
| pubmed-article:19958893 | pubmed:meshHeading | pubmed-meshheading:19958893... | lld:pubmed |
| pubmed-article:19958893 | pubmed:meshHeading | pubmed-meshheading:19958893... | lld:pubmed |
| pubmed-article:19958893 | pubmed:meshHeading | pubmed-meshheading:19958893... | lld:pubmed |
| pubmed-article:19958893 | pubmed:meshHeading | pubmed-meshheading:19958893... | lld:pubmed |
| pubmed-article:19958893 | pubmed:meshHeading | pubmed-meshheading:19958893... | lld:pubmed |
| pubmed-article:19958893 | pubmed:meshHeading | pubmed-meshheading:19958893... | lld:pubmed |
| pubmed-article:19958893 | pubmed:meshHeading | pubmed-meshheading:19958893... | lld:pubmed |
| pubmed-article:19958893 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19958893 | pubmed:articleTitle | Drug burden index score and functional decline in older people. | lld:pubmed |
| pubmed-article:19958893 | pubmed:affiliation | Intramural Research Program, National Institute on Aging, Baltimore and Bethesda, MD, USA. | lld:pubmed |
| pubmed-article:19958893 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19958893 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
| pubmed-article:19958893 | pubmed:publicationType | Research Support, N.I.H., Intramural | lld:pubmed |
